α-Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa

Mov Disord. 2018 Aug;33(8):1366-1368. doi: 10.1002/mds.27380.

Matej Skorvanek^{1

2

3}, Ellen Gelpi^{4

5}, Eva Mechirova⁶, Zuzana Ladomirjakova¹, Vladimir Han^{1

2}, Norbert Lesko^{1

2}, Eva Feketeova^{1

2}, Barbora Repkova¹, Zuzana Urbancikova¹, Adriana Vargova¹, Peter Spisak¹, Joaquim Ribeiro Ventosa¹, Filip Kudela¹, Kristina Kulcsarova¹, Simona Babinska¹, Stefan Toth⁶, Laura Gombosova⁷, Maria Zakuciova⁷, Eduard Veseliny⁷, Frantisek Trebuna⁸, Mirjam I Lutz⁴, Zuzana Gdovinova^{1

2}, Gabor G Kovacs⁴; PARCAS studygroup

¹ Department of Neurology, P. J. Safarik University, Kosice, Slovak Republic.
² Department of Neurology, University Hospital L. Pasteur, Kosice, Slovak Republic.
³ Centre of Experimental, Translational and Clinical Medicine, Technology and Innovation Park, P.J. Safarik University, Kosice, Slovakia.
⁴ Institute of Neurology, Medical University of Vienna, Vienna, Austria.
⁵ Neurological Tissue Bank of the Hospital Clinic-IDIBAPS (Institut d'Investigacions Biomediques August Pi i Sunyer) Biobank, Barcelona, Spain.
⁶ Department of Histology and Embryology, P. J. Safarik University, Kosice, Slovak Republic.
⁷ 1st Department of Internal Medicine, P. J. Safarik University, Kosice, Slovak Republic.
⁸ Gastroenterology Clinic Trebuna s.r.o., Kosice, Slovak Republic.

No abstract available

Publication types